Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 92

1.

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, Borràs FE, Bosch S, Boulanger CM, Breakefield X, Breglio AM, Brennan MÁ, Brigstock DR, Brisson A, Broekman ML, Bromberg JF, Bryl-Górecka P, Buch S, Buck AH, Burger D, Busatto S, Buschmann D, Bussolati B, Buzás EI, Byrd JB, Camussi G, Carter DR, Caruso S, Chamley LW, Chang YT, Chen C, Chen S, Cheng L, Chin AR, Clayton A, Clerici SP, Cocks A, Cocucci E, Coffey RJ, Cordeiro-da-Silva A, Couch Y, Coumans FA, Coyle B, Crescitelli R, Criado MF, D'Souza-Schorey C, Das S, Datta Chaudhuri A, de Candia P, De Santana EF, De Wever O, Del Portillo HA, Demaret T, Deville S, Devitt A, Dhondt B, Di Vizio D, Dieterich LC, Dolo V, Dominguez Rubio AP, Dominici M, Dourado MR, Driedonks TA, Duarte FV, Duncan HM, Eichenberger RM, Ekström K, El Andaloussi S, Elie-Caille C, Erdbrügger U, Falcón-Pérez JM, Fatima F, Fish JE, Flores-Bellver M, Försönits A, Frelet-Barrand A, Fricke F, Fuhrmann G, Gabrielsson S, Gámez-Valero A, Gardiner C, Gärtner K, Gaudin R, Gho YS, Giebel B, Gilbert C, Gimona M, Giusti I, Goberdhan DC, Görgens A, Gorski SM, Greening DW, Gross JC, Gualerzi A, Gupta GN, Gustafson D, Handberg A, Haraszti RA, Harrison P, Hegyesi H, Hendrix A, Hill AF, Hochberg FH, Hoffmann KF, Holder B, Holthofer H, Hosseinkhani B, Hu G, Huang Y, Huber V, Hunt S, Ibrahim AG, Ikezu T, Inal JM, Isin M, Ivanova A, Jackson HK, Jacobsen S, Jay SM, Jayachandran M, Jenster G, Jiang L, Johnson SM, Jones JC, Jong A, Jovanovic-Talisman T, Jung S, Kalluri R, Kano SI, Kaur S, Kawamura Y, Keller ET, Khamari D, Khomyakova E, Khvorova A, Kierulf P, Kim KP, Kislinger T, Klingeborn M, Klinke DJ 2nd, Kornek M, Kosanović MM, Kovács ÁF, Krämer-Albers EM, Krasemann S, Krause M, Kurochkin IV, Kusuma GD, Kuypers S, Laitinen S, Langevin SM, Languino LR, Lannigan J, Lässer C, Laurent LC, Lavieu G, Lázaro-Ibáñez E, Le Lay S, Lee MS, Lee YXF, Lemos DS, Lenassi M, Leszczynska A, Li IT, Liao K, Libregts SF, Ligeti E, Lim R, Lim SK, Linē A, Linnemannstöns K, Llorente A, Lombard CA, Lorenowicz MJ, Lörincz ÁM, Lötvall J, Lovett J, Lowry MC, Loyer X, Lu Q, Lukomska B, Lunavat TR, Maas SL, Malhi H, Marcilla A, Mariani J, Mariscal J, Martens-Uzunova ES, Martin-Jaular L, Martinez MC, Martins VR, Mathieu M, Mathivanan S, Maugeri M, McGinnis LK, McVey MJ, Meckes DG Jr, Meehan KL, Mertens I, Minciacchi VR, Möller A, Møller Jørgensen M, Morales-Kastresana A, Morhayim J, Mullier F, Muraca M, Musante L, Mussack V, Muth DC, Myburgh KH, Najrana T, Nawaz M, Nazarenko I, Nejsum P, Neri C, Neri T, Nieuwland R, Nimrichter L, Nolan JP, Nolte-'t Hoen EN, Noren Hooten N, O'Driscoll L, O'Grady T, O'Loghlen A, Ochiya T, Olivier M, Ortiz A, Ortiz LA, Osteikoetxea X, Østergaard O, Ostrowski M, Park J, Pegtel DM, Peinado H, Perut F, Pfaffl MW, Phinney DG, Pieters BC, Pink RC, Pisetsky DS, Pogge von Strandmann E, Polakovicova I, Poon IK, Powell BH, Prada I, Pulliam L, Quesenberry P, Radeghieri A, Raffai RL, Raimondo S, Rak J, Ramirez MI, Raposo G, Rayyan MS, Regev-Rudzki N, Ricklefs FL, Robbins PD, Roberts DD, Rodrigues SC, Rohde E, Rome S, Rouschop KM, Rughetti A, Russell AE, Saá P, Sahoo S, Salas-Huenuleo E, Sánchez C, Saugstad JA, Saul MJ, Schiffelers RM, Schneider R, Schøyen TH, Scott A, Shahaj E, Sharma S, Shatnyeva O, Shekari F, Shelke GV, Shetty AK, Shiba K, Siljander PR, Silva AM, Skowronek A, Snyder OL 2nd, Soares RP, Sódar BW, Soekmadji C, Sotillo J, Stahl PD, Stoorvogel W, Stott SL, Strasser EF, Swift S, Tahara H, Tewari M, Timms K, Tiwari S, Tixeira R, Tkach M, Toh WS, Tomasini R, Torrecilhas AC, Tosar JP, Toxavidis V, Urbanelli L, Vader P, van Balkom BW, van der Grein SG, Van Deun J, van Herwijnen MJ, Van Keuren-Jensen K, van Niel G, van Royen ME, van Wijnen AJ, Vasconcelos MH, Vechetti IJ Jr, Veit TD, Vella LJ, Velot É, Verweij FJ, Vestad B, Viñas JL, Visnovitz T, Vukman KV, Wahlgren J, Watson DC, Wauben MH, Weaver A, Webber JP, Weber V, Wehman AM, Weiss DJ, Welsh JA, Wendt S, Wheelock AM, Wiener Z, Witte L, Wolfram J, Xagorari A, Xander P, Xu J, Yan X, Yáñez-Mó M, Yin H, Yuana Y, Zappulli V, Zarubova J, Žėkas V, Zhang JY, Zhao Z, Zheng L, Zheutlin AR, Zickler AM, Zimmermann P, Zivkovic AM, Zocco D, Zuba-Surma EK.

J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018.

PMID:
30637094
2.

Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication.

Soares RP, Xander P, Costa AO, Marcilla A, Menezes-Neto A, Del Portillo H, Witwer K, Wauben M, Nolte-T Hoen E, Olivier M, Criado MF, da Silva LLP, Abdel Baqui MM, Schenkman S, Colli W, Alves MJM, Ferreira KS, Puccia R, Nejsum P, Riesbeck K, Stensballe A, Hansen EP, Jaular LM, Øvstebø R, de la Canal L, Bergese P, Pereira-Chioccola V, Pfaffl MW, Fritz J, Gho YS, Torrecilhas AC.

J Extracell Vesicles. 2017 Nov 26;6(1):1407213. doi: 10.1080/20013078.2017.1407213. eCollection 2017.

3.

Chronic Intake of Commercial Sweeteners Induces Changes in Feeding Behavior and Signaling Pathways Related to the Control of Appetite in BALB/c Mice.

Barrios-Correa AA, Estrada JA, Martel C, Olivier M, López-Santiago R, Contreras I.

Biomed Res Int. 2018 Jan 28;2018:3628121. doi: 10.1155/2018/3628121. eCollection 2018.

4.

Decreasing Revision Surgery in FAMM Flap Reconstruction of the Oral Cavity: Traditional Versus Modified Harvesting Technique.

Ibrahim B, Rahal A, Bissada E, Christopoulos A, Moubayed SP, Guertin L, Tabet JC, Olivier MJ, Ayad T.

Laryngoscope. 2018 Aug;128(8):1802-1805. doi: 10.1002/lary.27150. Epub 2018 Feb 26.

PMID:
29481692
5.

The circadian clock in immune cells controls the magnitude of Leishmania parasite infection.

Kiessling S, Dubeau-Laramée G, Ohm H, Labrecque N, Olivier M, Cermakian N.

Sci Rep. 2017 Sep 7;7(1):10892. doi: 10.1038/s41598-017-11297-8.

6.

HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases.

Cinti A, Le Sage V, Milev MP, Valiente-Echeverría F, Crossie C, Miron MJ, Panté N, Olivier M, Mouland AJ.

Sci Rep. 2017 Jul 14;7(1):5515. doi: 10.1038/s41598-017-05410-0.

7.

Protein Tyrosine Phosphatase Inhibition Prevents Experimental Cerebral Malaria by Precluding CXCR3 Expression on T Cells.

Van Den Ham KM, Smith LK, Richer MJ, Olivier M.

Sci Rep. 2017 Jul 14;7(1):5478. doi: 10.1038/s41598-017-05609-1.

8.

Hepatocyte SHP-1 is a Critical Modulator of Inflammation During Endotoxemia.

Adhikari A, Martel C, Marette A, Olivier M.

Sci Rep. 2017 May 22;7(1):2218. doi: 10.1038/s41598-017-02512-7.

9.

Perioperative practices in thyroid surgery: An international survey.

Maniakas A, Christopoulos A, Bissada E, Guertin L, Olivier MJ, Malaise J, Ayad T.

Head Neck. 2017 Jul;39(7):1296-1305. doi: 10.1002/hed.24722. Epub 2017 May 11.

PMID:
28493562
10.

Absence of apolipoprotein E protects mice from cerebral malaria.

Kassa FA, Van Den Ham K, Rainone A, Fournier S, Boilard E, Olivier M.

Sci Rep. 2016 Sep 20;6:33615. doi: 10.1038/srep33615.

11.

Leishmania exosomes and other virulence factors: Impact on innate immune response and macrophage functions.

Atayde VD, Hassani K, da Silva Lira Filho A, Borges AR, Adhikari A, Martel C, Olivier M.

Cell Immunol. 2016 Nov;309:7-18. doi: 10.1016/j.cellimm.2016.07.013. Epub 2016 Jul 28. Review.

PMID:
27499212
12.

Cysteine Peptidase B Regulates Leishmania mexicana Virulence through the Modulation of GP63 Expression.

Casgrain PA, Martel C, McMaster WR, Mottram JC, Olivier M, Descoteaux A.

PLoS Pathog. 2016 May 18;12(5):e1005658. doi: 10.1371/journal.ppat.1005658. eCollection 2016 May.

13.

Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut.

Atayde VD, Aslan H, Townsend S, Hassani K, Kamhawi S, Olivier M.

Cell Rep. 2015 Nov 3;13(5):957-67. doi: 10.1016/j.celrep.2015.09.058. Epub 2015 Oct 22.

14.

Voice and Functional Outcomes of Transoral Laser Microsurgery for Early Glottic Cancer: Ventricular Fold Resection as a Surrogate.

Berania I, Dagenais C, Moubayed SP, Ayad T, Olivier MJ, Guertin L, Bissada E, Tabet JC, Christopoulos A.

J Clin Med Res. 2015 Aug;7(8):632-6. doi: 10.14740/jocmr2216w. Epub 2015 Jun 9.

15.

PKC/ROS-Mediated NLRP3 Inflammasome Activation Is Attenuated by Leishmania Zinc-Metalloprotease during Infection.

Shio MT, Christian JG, Jung JY, Chang KP, Olivier M.

PLoS Negl Trop Dis. 2015 Jun 26;9(6):e0003868. doi: 10.1371/journal.pntd.0003868. eCollection 2015.

16.

Impact of Leishmania infection on host macrophage nuclear physiology and nucleopore complex integrity.

Isnard A, Christian JG, Kodiha M, Stochaj U, McMaster WR, Olivier M.

PLoS Pathog. 2015 Mar 31;11(3):e1004776. doi: 10.1371/journal.ppat.1004776. eCollection 2015 Mar.

17.

Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis.

Van Den Ham KM, Shio MT, Rainone A, Fournier S, Krawczyk CM, Olivier M.

PLoS One. 2015 Mar 13;10(3):e0118451. doi: 10.1371/journal.pone.0118451. eCollection 2015.

18.

Adaptation of Leishmania donovani to cutaneous and visceral environments: in vivo selection and proteomic analysis.

McCall LI, Zhang WW, Dejgaard K, Atayde VD, Mazur A, Ranasinghe S, Liu J, Olivier M, Nilsson T, Matlashewski G.

J Proteome Res. 2015 Feb 6;14(2):1033-59. doi: 10.1021/pr5010604. Epub 2015 Jan 13.

PMID:
25536015
19.

Impact of Leishmania mexicana infection on dendritic cell signaling and functions.

Contreras I, Estrada JA, Guak H, Martel C, Borjian A, Ralph B, Shio MT, Fournier S, Krawczyk CM, Olivier M.

PLoS Negl Trop Dis. 2014 Sep 25;8(9):e3202. doi: 10.1371/journal.pntd.0003202. eCollection 2014 Sep.

20.

Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002.

Couraud S, Vaca-Paniagua F, Villar S, Oliver J, Schuster T, Blanché H, Girard N, Trédaniel J, Guilleminault L, Gervais R, Prim N, Vincent M, Margery J, Larivé S, Foucher P, Duvert B, Vallee M, Le Calvez-Kelm F, McKay J, Missy P, Morin F, Zalcman G, Olivier M, Souquet PJ; BioCAST/IFCT-1002 investigators.

Clin Cancer Res. 2014 Sep 1;20(17):4613-24. doi: 10.1158/1078-0432.CCR-13-3063. Epub 2014 Jul 10.

21.

Absence of metalloprotease GP63 alters the protein content of Leishmania exosomes.

Hassani K, Shio MT, Martel C, Faubert D, Olivier M.

PLoS One. 2014 Apr 15;9(4):e95007. doi: 10.1371/journal.pone.0095007. eCollection 2014.

22.

Drug delivery by tattooing to treat cutaneous leishmaniasis.

Shio MT, Paquet M, Martel C, Bosschaerts T, Stienstra S, Olivier M, Fortin A.

Sci Rep. 2014 Feb 24;4:4156. doi: 10.1038/srep04156.

23.

Malarial pigment hemozoin and the innate inflammatory response.

Olivier M, Van Den Ham K, Shio MT, Kassa FA, Fougeray S.

Front Immunol. 2014 Feb 5;5:25. doi: 10.3389/fimmu.2014.00025. eCollection 2014. Review.

24.

Impact of neutrophil-secreted myeloid related proteins 8 and 14 (MRP 8/14) on leishmaniasis progression.

Contreras I, Shio MT, Cesaro A, Tessier PA, Olivier M.

PLoS Negl Trop Dis. 2013 Sep 26;7(9):e2461. doi: 10.1371/journal.pntd.0002461. eCollection 2013.

25.

Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8.

Matheoud D, Moradin N, Bellemare-Pelletier A, Shio MT, Hong WJ, Olivier M, Gagnon E, Desjardins M, Descoteaux A.

Cell Host Microbe. 2013 Jul 17;14(1):15-25. doi: 10.1016/j.chom.2013.06.003.

26.

Immunomodulatory impact of leishmania-induced macrophage exosomes: a comparative proteomic and functional analysis.

Hassani K, Olivier M.

PLoS Negl Trop Dis. 2013 May 2;7(5):e2185. doi: 10.1371/journal.pntd.0002185. Print 2013.

27.

Impact of Leishmania metalloprotease GP63 on macrophage signaling.

Isnard A, Shio MT, Olivier M.

Front Cell Infect Microbiol. 2012 May 16;2:72. doi: 10.3389/fcimb.2012.00072. eCollection 2012. Review.

28.

Leishmania virulence factors: focus on the metalloprotease GP63.

Olivier M, Atayde VD, Isnard A, Hassani K, Shio MT.

Microbes Infect. 2012 Dec;14(15):1377-89. doi: 10.1016/j.micinf.2012.05.014. Epub 2012 Jun 6. Review.

PMID:
22683718
29.

Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.

Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, Olivier M, Piccirillo CA.

PLoS One. 2012;7(4):e35572. doi: 10.1371/journal.pone.0035572. Epub 2012 Apr 24.

30.

Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E.

Herdy B, Jaramillo M, Svitkin YV, Rosenfeld AB, Kobayashi M, Walsh D, Alain T, Sean P, Robichaud N, Topisirovic I, Furic L, Dowling RJO, Sylvestre A, Rong L, Colina R, Costa-Mattioli M, Fritz JH, Olivier M, Brown E, Mohr I, Sonenberg N.

Nat Immunol. 2012 Apr 29;13(6):543-550. doi: 10.1038/ni.2291.

31.

Prognostic value of cartilage sclerosis in laryngeal cancer treated with primary radiation therapy.

Moubayed SP, Bélair M, Saliba J, Bibeau-Poirier J, Christopoulos A, Nguyen-Tan PF, Guertin L, Lambert L, Olivier MJ, Ayad T.

Otolaryngol Head Neck Surg. 2012 Jul;147(1):57-62. doi: 10.1177/0194599812438181. Epub 2012 Feb 21.

PMID:
22357645
32.

Immunization against Leishmania major infection using LACK- and IL-12-expressing Lactococcus lactis induces delay in footpad swelling.

Hugentobler F, Yam KK, Gillard J, Mahbuba R, Olivier M, Cousineau B.

PLoS One. 2012;7(2):e30945. doi: 10.1371/journal.pone.0030945. Epub 2012 Feb 10.

33.

Host cell signalling and leishmania mechanisms of evasion.

Shio MT, Hassani K, Isnard A, Ralph B, Contreras I, Gomez MA, Abu-Dayyeh I, Olivier M.

J Trop Med. 2012;2012:819512. doi: 10.1155/2012/819512. Epub 2011 Nov 3.

34.

New inflammation-related biomarkers during malaria infection.

Kassa FA, Shio MT, Bellemare MJ, Faye B, Ndao M, Olivier M.

PLoS One. 2011;6(10):e26495. doi: 10.1371/journal.pone.0026495. Epub 2011 Oct 20.

35.

Temperature-induced protein secretion by Leishmania mexicana modulates macrophage signalling and function.

Hassani K, Antoniak E, Jardim A, Olivier M.

PLoS One. 2011 May 3;6(5):e18724. doi: 10.1371/journal.pone.0018724.

36.

Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB/c mice.

Yam KK, Hugentobler F, Pouliot P, Stern AM, Lalande JD, Matlashewski G, Olivier M, Cousineau B.

J Med Microbiol. 2011 Sep;60(Pt 9):1248-60. doi: 10.1099/jmm.0.029959-0. Epub 2011 Apr 28.

PMID:
21527547
37.

Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection.

Jaramillo M, Gomez MA, Larsson O, Shio MT, Topisirovic I, Contreras I, Luxenburg R, Rosenfeld A, Colina R, McMaster RW, Olivier M, Costa-Mattioli M, Sonenberg N.

Cell Host Microbe. 2011 Apr 21;9(4):331-41. doi: 10.1016/j.chom.2011.03.008.

38.

Neonatal squamous cell carcinoma of the lip: case report and review of the literature.

Moubayed SP, Chami R, Woods O, Olivier MJ, Dal Soglio DB, Lapointe A.

J Clin Oncol. 2011 Jun 20;29(18):e549-52. doi: 10.1200/JCO.2011.34.7658. Epub 2011 Apr 11. Review. No abstract available.

PMID:
21482980
39.

Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63.

Contreras I, Gómez MA, Nguyen O, Shio MT, McMaster RW, Olivier M.

PLoS Pathog. 2010 Oct 14;6(10):e1001148. doi: 10.1371/journal.ppat.1001148.

40.

In vitro characterization of the microglial inflammatory response to Streptococcus suis, an important emerging zoonotic agent of meningitis.

Domínguez-Punaro Mde L, Segura M, Contreras I, Lachance C, Houde M, Lecours MP, Olivier M, Gottschalk M.

Infect Immun. 2010 Dec;78(12):5074-85. doi: 10.1128/IAI.00698-10. Epub 2010 Sep 27.

41.

Innate inflammatory response to the malarial pigment hemozoin.

Shio MT, Kassa FA, Bellemare MJ, Olivier M.

Microbes Infect. 2010 Nov;12(12-13):889-99. doi: 10.1016/j.micinf.2010.07.001. Epub 2010 Jul 15. Review.

PMID:
20637890
42.

Protein tyrosine phosphatases are regulated by mononuclear iron dicitrate.

Gomez MA, Alisaraie L, Shio MT, Berghuis AM, Lebrun C, Gautier-Luneau I, Olivier M.

J Biol Chem. 2010 Aug 6;285(32):24620-8. doi: 10.1074/jbc.M110.107037. Epub 2010 Jun 2.

43.

Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions.

Abu-Dayyeh I, Hassani K, Westra ER, Mottram JC, Olivier M.

Infect Immun. 2010 Jun;78(6):2438-45. doi: 10.1128/IAI.00812-09. Epub 2010 Apr 5.

44.

The IL-12p70/IL-10 interplay is differentially regulated by free heme and hemozoin in murine bone-marrow-derived macrophages.

Cambos M, Bazinet S, Abed E, Sanchez-Dardon J, Bernard C, Moreau R, Olivier M, Scorza T.

Int J Parasitol. 2010 Aug 1;40(9):1003-12. doi: 10.1016/j.ijpara.2010.02.007. Epub 2010 Mar 6.

PMID:
20211185
45.

Identification of key cytosolic kinases containing evolutionarily conserved kinase tyrosine-based inhibitory motifs (KTIMs).

Abu-Dayyeh I, Ralph B, Grayfer L, Belosevic M, Cousineau B, Olivier M.

Dev Comp Immunol. 2010 May;34(5):481-4. doi: 10.1016/j.dci.2009.12.012. Epub 2010 Jan 5.

PMID:
20043942
46.

The role of protein tyrosine phosphatases in the regulation of allergic asthma: implication of TC-PTP and PTP-1B in the modulation of disease development.

Pouliot P, Bergeron S, Marette A, Olivier M.

Immunology. 2009 Dec;128(4):534-42. doi: 10.1111/j.1365-2567.2009.03139.x.

47.

Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases.

Gomez MA, Contreras I, Hallé M, Tremblay ML, McMaster RW, Olivier M.

Sci Signal. 2009 Sep 29;2(90):ra58. doi: 10.1126/scisignal.2000213.

48.

Synthetic Plasmodium-like hemozoin activates the immune response: a morphology - function study.

Jaramillo M, Bellemare MJ, Martel C, Shio MT, Contreras AP, Godbout M, Roger M, Gaudreault E, Gosselin J, Bohle DS, Olivier M.

PLoS One. 2009 Sep 9;4(9):e6957. doi: 10.1371/journal.pone.0006957.

49.

Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases.

Shio MT, Eisenbarth SC, Savaria M, Vinet AF, Bellemare MJ, Harder KW, Sutterwala FS, Bohle DS, Descoteaux A, Flavell RA, Olivier M.

PLoS Pathog. 2009 Aug;5(8):e1000559. doi: 10.1371/journal.ppat.1000559. Epub 2009 Aug 21. Erratum in: PLoS Pathog. 2009 Sep;5(9). doi: 10.1371/annotation/abca067d-b82b-4de6-93c5-0fcc38e3df05. Tiemi Shio, Marina [corrected to Shio, Marina Tiemi].

50.

Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation.

Urb M, Pouliot P, Gravelat FN, Olivier M, Sheppard DC.

J Infect Dis. 2009 Aug 1;200(3):464-72. doi: 10.1086/600070.

PMID:
19527167
51.

Autofluorescence of condensed heme aggregates in malaria pigment and its synthetic equivalent hematin anhydride (beta-hematin).

Bellemare MJ, Bohle DS, Brosseau CN, Georges E, Godbout M, Kelly J, Leimanis ML, Leonelli R, Olivier M, Smilkstein M.

J Phys Chem B. 2009 Jun 18;113(24):8391-401. doi: 10.1021/jp8104375.

PMID:
19472980
52.

Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?

Barkati M, Fortin B, Soulières D, Clavel S, Després P, Charpentier D, Tabet JC, Guertin L, Olivier MJ, Coulombe G, Donath D, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):410-6. doi: 10.1016/j.ijrobp.2009.02.034. Epub 2009 May 8.

PMID:
19427745
53.

Protein tyrosine phosphatases regulate asthma development in a murine asthma model.

Pouliot P, Camateros P, Radzioch D, Lambrecht BN, Olivier M.

J Immunol. 2009 Feb 1;182(3):1334-40.

54.

Host-pathogen interactions of Actinobacillus pleuropneumoniae with porcine lung and tracheal epithelial cells.

Auger E, Deslandes V, Ramjeet M, Contreras I, Nash JH, Harel J, Gottschalk M, Olivier M, Jacques M.

Infect Immun. 2009 Apr;77(4):1426-41. doi: 10.1128/IAI.00297-08. Epub 2009 Jan 12.

55.

Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif.

Abu-Dayyeh I, Shio MT, Sato S, Akira S, Cousineau B, Olivier M.

PLoS Negl Trop Dis. 2008;2(12):e305. doi: 10.1371/journal.pntd.0000305. Epub 2008 Dec 23.

56.

The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation.

Hallé M, Gomez MA, Stuible M, Shimizu H, McMaster WR, Olivier M, Tremblay ML.

J Biol Chem. 2009 Mar 13;284(11):6893-908. doi: 10.1074/jbc.M805861200. Epub 2008 Dec 8.

57.

Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1).

Blanchette J, Abu-Dayyeh I, Hassani K, Whitcombe L, Olivier M.

Immunology. 2009 May;127(1):123-33. doi: 10.1111/j.1365-2567.2008.02929.x.

58.

Myeloid-related proteins rapidly modulate macrophage nitric oxide production during innate immune response.

Pouliot P, Plante I, Raquil MA, Tessier PA, Olivier M.

J Immunol. 2008 Sep 1;181(5):3595-601.

59.

Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis.

Yam KK, Pouliot P, N'diaye MM, Fournier S, Olivier M, Cousineau B.

Vaccine. 2008 May 23;26(22):2689-99. doi: 10.1016/j.vaccine.2008.03.024. Epub 2008 Apr 3.

PMID:
18436352
60.

A novel form of NF-kappaB is induced by Leishmania infection: involvement in macrophage gene expression.

Gregory DJ, Godbout M, Contreras I, Forget G, Olivier M.

Eur J Immunol. 2008 Apr;38(4):1071-81. doi: 10.1002/eji.200737586.

61.

Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression.

Gregory DJ, Sladek R, Olivier M, Matlashewski G.

Infect Immun. 2008 Mar;76(3):1186-92. Epub 2007 Dec 17.

62.

NRAMP-1 expression modulates protein-tyrosine phosphatase activity in macrophages: impact on host cell signaling and functions.

Gomez MA, Li S, Tremblay ML, Olivier M.

J Biol Chem. 2007 Dec 14;282(50):36190-8. Epub 2007 Oct 17.

63.

Trypanocidal and antileishmanial dihydrochelerythrine derivatives from Garcinia lucida.

Fotie J, Bohle DS, Olivier M, Adelaida Gomez M, Nzimiro S.

J Nat Prod. 2007 Oct;70(10):1650-3. Epub 2007 Sep 20.

PMID:
17880175
64.

Identification and characterization of a protein-tyrosine phosphatase in Leishmania: Involvement in virulence.

Nascimento M, Zhang WW, Ghosh A, Houston DR, Berghuis AM, Olivier M, Matlashewski G.

J Biol Chem. 2006 Nov 24;281(47):36257-68. Epub 2006 Sep 27.

65.

Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma.

Forest VI, Nguyen-Tan PF, Tabet JC, Olivier MJ, Larochelle D, Fortin B, Gélinas M, Soulières D, Charpentier D, Guertin L.

Head Neck. 2006 Dec;28(12):1099-105.

PMID:
16933313
66.

Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system.

Segura M, Vanier G, Al-Numani D, Lacouture S, Olivier M, Gottschalk M.

FEMS Immunol Med Microbiol. 2006 Jun;47(1):92-106.

67.

Subversion of host cell signalling by the protozoan parasite Leishmania.

Gregory DJ, Olivier M.

Parasitology. 2005;130 Suppl:S27-35. Review.

PMID:
16281989
68.

Resistance mechanism development to the topoisomerase-I inhibitor Hoechst 33342 by Leishmania donovani.

Marquis JF, Hardy I, Olivier M.

Parasitology. 2005 Aug;131(Pt 2):197-206.

PMID:
16145936
69.

Retromolar trigone carcinoma treated by primary radiation therapy: an alternative to the primary surgical approach.

Ayad T, Gélinas M, Guertin L, Larochelle D, Del Vecchio P, Tabet JC, Olivier MJ, Soulières D, Charpentier D, Nguyen-Tân PF.

Arch Otolaryngol Head Neck Surg. 2005 Jul;131(7):576-82.

PMID:
16027279
70.

Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Olivier M, Gregory DJ, Forget G.

Clin Microbiol Rev. 2005 Apr;18(2):293-305. Review.

71.
72.

Dental care pathway of Quebecers after a broken filling.

Bedos C, Brodeur JM, Benigeri M, Olivier M.

Community Dent Health. 2004 Dec;21(4):277-84.

PMID:
15617412
73.
74.

Signaling events involved in macrophage chemokine expression in response to monosodium urate crystals.

Jaramillo M, Godbout M, Naccache PH, Olivier M.

J Biol Chem. 2004 Dec 10;279(50):52797-805. Epub 2004 Oct 7.

75.

[Social inequalities in the demand for dental care].

Bedos C, Brodeur JM, Benigeri M, Olivier M.

Rev Epidemiol Sante Publique. 2004 Jun;52(3):261-70. French.

PMID:
15356439
76.
77.

The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms.

Olivier M, Badaró R, Medrano FJ, Moreno J.

Ann Trop Med Parasitol. 2003 Oct;97 Suppl 1:79-98. Review.

PMID:
14678636
78.

The dental care pathway of welfare recipients in Quebec.

Bedos C, Brodeur JM, Boucheron L, Richard L, Benigeri M, Olivier M, Haddad S.

Soc Sci Med. 2003 Dec;57(11):2089-99.

PMID:
14512240
79.

Parental factors associated with regular use of dental services by second-year secondary school students in Quebec.

Scott G, Brodeur JM, Olivier M, Benigeri M.

J Can Dent Assoc. 2002 Nov;68(10):604-8.

80.

[Knowledge and perceptions of adolescents regarding oral health].

Benigeri M, Brodeur JM, Olivier M, Bedos C.

Can J Public Health. 2002 Jan-Feb;93(1):54-8. French.

PMID:
11925702
81.

Periodontal diseases among Quebec adults aged 35 to 44 years.

Brodeur JM, Payette M, Beniger M, Charbonneau A, Olivier M, Chabot D.

J Can Dent Assoc. 2001 Jan;67(1):34.

82.

Dental caries in Quebec adults aged 35 to 44 years.

Brodeur JM, Payette M, Benigeri M, Gagnon PF, Olivier M, Chabot D.

J Can Dent Assoc. 2000 Jul-Aug;66(7):374-9.

83.

My sister's death.

Olivier M.

Inj Prev. 1999 Jun;5(2):89-90. No abstract available.

84.

Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase.

Broccoli S, Marquis JF, Papadopoulou B, Olivier M, Drolet M.

Nucleic Acids Res. 1999 Jul 1;27(13):2745-52.

85.

Restorative treatments received by children covered by a universal, publicly financed, dental insurance plan.

Ismail A, Brodeur JM, Gagnon P, Payette M, Picard D, Hamalian T, Olivier M.

J Public Health Dent. 1997 Winter;57(1):11-8.

PMID:
9150059
86.

[Use of dental services and the percentage of persons possessing private dental insurance in Québec].

Brodeur JM, Benigeri M, Olivier M, Payette M.

J Can Dent Assoc. 1996 Jan;62(1):83-90. French.

PMID:
8673943
87.

Prosthetic relining and dietary counselling in elderly women.

Olivier M, Laurin D, Brodeur JM, Boivin M, Leduc N, Lévy M, Taché RH.

J Can Dent Assoc. 1995 Oct;61(10):882-6.

PMID:
7497335
88.

The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene.

Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, Malo D, Skamene E, Olivier M, Jothy S, Gros P.

J Exp Med. 1995 Sep 1;182(3):655-66.

89.

Prevalence of non-cavitated and cavitated carious lesions in a random sample of 7-9-year-old schoolchildren in Montreal, Quebec.

Ismail AI, Brodeur JM, Gagnon P, Payette M, Picard D, Hamalian T, Olivier M, Eastwood BJ.

Community Dent Oral Epidemiol. 1992 Oct;20(5):250-5.

PMID:
1424542
90.

Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome.

Kramer MS, Olivier M, McLean FH, Willis DM, Usher RH.

Pediatrics. 1990 Nov;86(5):707-13.

PMID:
2235224
91.

Determinants of fetal growth and body proportionality.

Kramer MS, Olivier M, McLean FH, Dougherty GE, Willis DM, Usher RH.

Pediatrics. 1990 Jul;86(1):18-26.

PMID:
2359680
92.

Body proportionality and head and length 'sparing' in growth-retarded neonates: a critical reappraisal.

Kramer MS, McLean FH, Olivier M, Willis DM, Usher RH.

Pediatrics. 1989 Oct;84(4):717-23.

PMID:
2780135

Supplemental Content

Loading ...
Support Center